Choose your location
Select your country or region to view content specific to your country.
Our Product
-
2019-nCoV Assay
Allplex™ 2019-nCoV Assay is multiplex Real-time PCR assay for simultaneous detection of 3 target genes of SARS-CoV-2 in a single tube. The assay is designed to detect RdRP and N genes specific for SARS-CoV-2, and E gene for all of Sarbecovirus including SARS-CoV-2.
-
2019-nCoV Assay (USA Only)
Allplex™ 2019-nCoV Assay is a multiplex Real-time PCR assay for simultaneous detection of 3 target genes of SARS-CoV-2 in a single tube. The assay is designed to detect RdRP and N genes specific for SARS-CoV-2, and E gene for all of Sarbecovirus including SARS-CoV-2.
-
RV Master Assay
Allplex™ RV Master Assay is Seegene’s comprehensive respiratory testing solution. Accurate and rapid identification of various major respiratory viruses (Flu A, Flu B, RSV, MPV, AdV, HRV and PIV), including SARS-CoV-2, enables appropriate prescription and response.
-
SARS-CoV-2 fast MDX Assay
-
SARS-CoV-2 fast PCR Assay
-
SARS-CoV-2 Variants I Assay
Allplex™ SARS-CoV-2 Variants I Assay is a multiplex real-time PCR assay that detects and identifies three notable mutation sites in S gene including HV69/70 deletion, E484K and N501Y and highly conserved region in RdRP gene in one tube.
-
SARS-CoV-2 Assay
Allplex™ SARS-CoV-2 Assay is a multiplex real-time PCR assay to detect 4 target genes of SARS-CoV-2, causing COVID-19 in a single tube. The assay is designed to detect RdRP, S and N genes specific for SARS-CoV-2, and E gene for all of Sarbecovirus including SARS-CoV-2. It can be applied on Seegene’s automated system that enables high throughput testing.
-
SARS-CoV-2/FluA/FluB/RSV Assay
Allplex™ SARS-CoV-2/Flu A/Flu B/RSV Assay is a multiplex real-time PCR assay designed to detect N gene, RdRP gene and S gene for SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus (RSV) A/B in a single tube. The assay is applied on Seegene’s integrated All-in-One automated platform which enables high-throughput testing.
-
SARS-CoV-2 Variants II Assay
Allplex™ SARS-CoV-2 Variants II Assay is a multiplex real-time PCR assay that detects and identifies four notable SARS-CoV-2 S gene mutations (L452R, W152C, K417T, and K417N) in a single tube.
News & Media
Video Clip
-
Event
Seegene announces ‘$12 PCR Testing’ initiative to help end COVID-19 pandemic
May 31, 2022
-
Event
Introducing the Workflow of Seegene Allplex™ SARS-CoV-2 fast PCR Assay
Feb 18, 2022
-
Event
Introducing Seegene Allplex™ SARS-CoV-2 fast PCR Assay
Jan 24, 2022
-
Event
Seegene Omicron Response: Q&A Session with Dr. Yun-Jee Kim
Dec 07, 2021
-
Event
How Seegene is Responding to Omicron
Dec 01, 2021
-
Event
Screening and Identification of SARS-CoV-2&Variants
Apr 01, 2021
-
Event
Allplex™ SARS-CoV-2/Flu A/Flu B/RSV Assay
Sep 11, 2020
-
Event
Allplex™ SARS-CoV-2 Assay
Sep 11, 2020
News
-
Product News
Obtained Australian TGA approval for Allplex™ SARS-CoV-2 fast PCR Assay
Apr 12, 2022
-
Product News
Obtained CE-IVD marking for Allplex™ SARS-CoV-2 fast MDx Assay
Feb 25, 2022
-
Product News
Obtained CE-IVD marking for Allplex™ SARS-CoV-2 fast PCR Assay
Dec 29, 2021
-
Product News
Launched Novaplex™ SARS-CoV-2 Variants VII Assay
Dec 20, 2021
-
Press Release
Seegene Introduces New SARS-CoV-2 Variants Detection Test That Can Screen Six Virus Variants Including the Delta and Delta Plus
Jul 13, 2021
-
Product News
Obtained CE-IVD marking for Allplex™ SARS-CoV-2 Variants II Assay
Jun 30, 2021
-
Product News
Obtained CE-IVD marking for Allplex™ SARS-CoV-2 Master Assay
Mar 26, 2021
-
Product News
Obtained CE-IVD marking for Allplex™ SARS-CoV-2 Variants I Assay
Mar 26, 2021
-
Press Release
Seegene Announces Submission to U.S. FDA for Emergency Use Authorization of Its Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay
Mar 03, 2021
-
Press Release
Seegene’s Latest COVID-19 Test Can Simultaneously Target 4 Genes of SARS-CoV-2 and Recognize Multiple Virus Variants
Mar 03, 2021
-
Product News
Obtained approval of MFDS for Allplex™ SARS-CoV-2/Flu A/Flu B/RSV Assay
Jan 26, 2021
-
Product News
Obtained approval of MFDS for Allplex™ SARS-CoV-2 Assay
Dec 07, 2020
-
Product News
Obtained CE-IVD marking for Allplex™ SARS-CoV-2/Flu A/Flu B/RSV Assay
Sep 15, 2020
-
Product News
Obtained CE-IVD marking for Allplex™ SARS-CoV-2 Assay
Apr 03, 2020
